Patent · US Expired

Anthracycline compounds

US4550159A · kind A · utility

3Cited by
6References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 1983
Grant dateOct 29, 1985
Priority date
Expiry dateOct 25, 2003

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12R2001/465
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

An anthracycline compound, ditrisarubicin, of the formula: ##STR1## wherein R represents one of the following substituents (A), (B), and (C): ##STR2## is produced by a process which comprises cultivating a strain of Streptomyces in a suitable culture medium under aerobic conditions, said strain having the ability to produce the anthracycline compound, ditrisarubicin, and then recovering the anthracycline compound, ditrisarubicin, from the cultured medium. This ditrisarubicin, or an acid addition salt of the ditrisarubicin, can be contained as the active ingredient in antitumor agents and in pharmaceutical compositions for treatment of infections induced by gram-positive microorganisms, whereby good results are attainable.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.